We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

74 hedge funds and large institutions have $665M invested in Akcea Therapeutics Inc in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 4

127% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 15

35% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $11.9M

19% more funds holding

Funds holding: 62 → 74 (+12)

6% less capital invested

Capital invested by funds: $704M → $665M (-$39.1M)

Holders
74
Holders Change
+12
Holders Change %
+19.35%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
34
Reduced
15
Closed
4
Calls
$16.1M
Puts
$11.9M
Net Calls
+$4.17M
Net Calls Change
-$858K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$12.3M
2
State Street
State Street
Massachusetts
+$7.34M
3
SC
Sculptor Capital
New York
+$2.71M
4
IBT
International Biotechnology Trust
United Kingdom
+$2.17M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.38M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$19.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.57M
3
BlackRock
BlackRock
New York
-$3.65M
4
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$825K
5
AGA
Altrinsic Global Advisors
Connecticut
-$728K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$966K +$664K +22,806 +202%
Swiss National Bank
27
Swiss National Bank
Switzerland
$921K +$64.1K +2,200 +7%
ProShare Advisors
28
ProShare Advisors
Maryland
$900K +$4.81K +165 +0.5%
TCIM
29
TIAA CREF Investment Management
New York
$818K -$5.48K -188 -0.6%
CS
30
Credit Suisse
Switzerland
$764K +$376K +12,904 +92%
QCM
31
Quantinno Capital Management
New York
$758K +$780K +26,770 New
AllianceBernstein
32
AllianceBernstein
Tennessee
$748K -$78.6K -2,700 -9%
AQR Capital Management
33
AQR Capital Management
Connecticut
$694K +$77.4K +2,657 +12%
Rafferty Asset Management
34
Rafferty Asset Management
New York
$678K +$697K +23,928 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$584K +$27.9K +957 +5%
Squarepoint
36
Squarepoint
New York
$562K +$185K +6,337 +47%
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$558K +$569K +19,523 +11,030%
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$487K +$117K +4,000 +30%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$486K +$11.9K +409 +2%
ARTA
40
A.R.T. Advisors
New York
$417K +$428K +14,707 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$402K – – –
MC
42
Menta Capital
California
$306K +$315K +10,800 New
Barclays
43
Barclays
United Kingdom
$302K +$125K +4,294 +67%
VEA
44
Virtus ETF Advisers
New York
$242K -$31.5K -1,083 -11%
WCM
45
Weld Capital Management
New York
$240K -$41.9K -1,440 -15%
AIG
46
American International Group
New York
$240K +$2.45K +84 +1%
Invesco
47
Invesco
Georgia
$234K -$39.6K -1,360 -14%
PPA
48
Parametric Portfolio Associates
Washington
$216K -$31.5K -1,083 -12%
MIM
49
MetLife Investment Management
New Jersey
$208K – – –
UBS AM
50
UBS AM
Illinois
$203K +$208K +7,156 New
1
2
3 4

AKCA Hedge Fund Activity: Q1 2019 in Review

74 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q1 2019, worth a combined $665M — down 5.6% from $704M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AKCA positions and 4 closed out — a net gain of 12 holders — while 34 added to existing stakes and 15 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $12.3M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $19.3M sold.

  • 74 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q1 2019, up from 62 in Q4 2018.
  • Funds reported $665M of Akcea Therapeutics Inc stock for Q1 2019, down 5.6% quarter-over-quarter.
  • 16 funds opened new Akcea Therapeutics Inc positions in Q1 2019 and 4 closed out, a net change of +12 holders.
  • The largest Akcea Therapeutics Inc buyer in Q1 2019 was Citadel Advisors, an estimated $12.3M added.
  • The largest Akcea Therapeutics Inc seller in Q1 2019 was EcoR1 Capital, an estimated $19.3M sold.

Based on aggregated 13F filings for Q1 2019.